EDGAR Filing Documents for 0001104659-22-084301

Form 8-K - Current report:

SEC Accession No. 0001104659-22-084301

Filing Date

2022-07-29

Accepted

2022-07-29 16:50:42

Documents

Period of Report

2022-07-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2222078d1_8k.htm iXBRL	8-K	41364
2	EXHIBIT 3.1	tm2222078d1_ex3-1.htm	EX-3.1	91815
3	EXHIBIT 3.2	tm2222078d1_ex3-2.htm	EX-3.2	92432
4	EXHIBIT 10.1	tm2222078d1_ex10-1.htm	EX-10.1	196649
5	EXHIBIT 99.1	tm2222078d1_ex99-1.htm	EX-99.1	13920
	Complete submission text file	0001104659-22-084301.txt		718079

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	syn-20220728.xsd	EX-101.SCH	3060
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	syn-20220728_lab.xml	EX-101.LAB	34476
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	syn-20220728_pre.xml	EX-101.PRE	22614
10	EXTRACTED XBRL INSTANCE DOCUMENT	tm2222078d1_8k_htm.xml	XML	3728

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850

Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800

Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)